Cargando…

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

In response to major changes in diagnostic algorithms and the publication of mature results from various large clinical trials, the European Association of Neuro-Oncology (EANO) recognized the need to provide updated guidelines for the diagnosis and management of adult patients with diffuse gliomas....

Descripción completa

Detalles Bibliográficos
Autores principales:	Weller, Michael, van den Bent, Martin, Preusser, Matthias, Le Rhun, Emilie, Tonn, Jörg C., Minniti, Giuseppe, Bendszus, Martin, Balana, Carmen, Chinot, Olivier, Dirven, Linda, French, Pim, Hegi, Monika E., Jakola, Asgeir S., Platten, Michael, Roth, Patrick, Rudà, Roberta, Short, Susan, Smits, Marion, Taphoorn, Martin J. B., von Deimling, Andreas, Westphal, Manfred, Soffietti, Riccardo, Reifenberger, Guido, Wick, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Evidence-Based Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904519/ https://www.ncbi.nlm.nih.gov/pubmed/33293629 http://dx.doi.org/10.1038/s41571-020-00447-z

Ejemplares similares

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
por: Weller, Michael, et al.
Publicado: (2022)

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
por: Le Rhun, E., et al.
Publicado: (2023)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection
por: Capper, David, et al.
Publicado: (2023)

41. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline
por: Sahm, Felix, et al.
Publicado: (2023)

Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee
por: Kiesel, Barbara, et al.
Publicado: (2020)

SURG-10. The evolving role of neurosurgery for central nervous system metastases in the era of personalized medicine
por: Karschnia, Philipp, et al.
Publicado: (2021)

How we treat patients with leptomeningeal metastases
por: Le Rhun, Emilie, et al.
Publicado: (2019)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
por: Kessler, Tobias, et al.
Publicado: (2023)

The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO
por: Kim, Young Zoon, et al.
Publicado: (2022)

Editorial: Investigating the gliomas/white matter interplay and its implications for multidisciplinary treatment: State of art and future perspectives
por: Latini, Francesco, et al.
Publicado: (2022)

DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients
por: Bady, Pierre, et al.
Publicado: (2022)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
por: Kessler, Tobias, et al.
Publicado: (2020)

Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma
por: Seidel, Clemens, et al.
Publicado: (2011)

The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033
por: Bady, Pierre, et al.
Publicado: (2018)

Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults
por: Weller, Michael, et al.
Publicado: (2023)

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0
por: Law, Ian, et al.
Publicado: (2018)

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
por: Coomans, Marijke B, et al.
Publicado: (2022)

Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
por: Seystahl, Katharina, et al.
Publicado: (2022)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
por: Coomans, Marijke B, et al.
Publicado: (2019)

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients
por: Coomans, Marijke B, et al.
Publicado: (2020)

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling
por: Coomans, Marijke B, et al.
Publicado: (2020)

AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
por: Bunse, Lukas, et al.
Publicado: (2022)

Anti-VEGF drugs: evidence for effectiveness
por: Evans, Jennifer, et al.
Publicado: (2014)

Corrigendum: Prescription preferences of antiepileptic drugs in brain tumor patients: an international survey among EANO members
Publicado: (2022)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
por: Boire, Adrienne, et al.
Publicado: (2019)

IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma
por: Kickingereder, Philipp, et al.
Publicado: (2015)

Vitamin D and COVID-19: evidence and recommendations for supplementation
por: Griffin, George, et al.
Publicado: (2020)

Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up
por: Pertz, Milena, et al.
Publicado: (2023)

Mechanisms and Therapy for Cancer Metastasis to the Brain
por: Franchino, Federica, et al.
Publicado: (2018)

Brain Metastasis from Unknown Primary Tumour: Moving from Old Retrospective Studies to Clinical Trials on Targeted Agents
por: Balestrino, Roberta, et al.
Publicado: (2020)

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
por: Preusser, Matthias, et al.
Publicado: (2015)

A restatement of the natural science evidence base regarding the source, spread and control of Campylobacter species causing human disease
por: Goddard, Matthew R., et al.
Publicado: (2022)

Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis—a safety analysis and validation of the EANO-ESMO classification
por: Iglseder, Sarah, et al.
Publicado: (2022)

EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults
por: Frappaz, Didier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h47bckc04qf6sse7dg8tpvf3hc